| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 53.13▲ | 53.29▲ | 53.45▼ | 51.74▲ | 52.96▲ |
| MA10 | 53.08▲ | 53.71▼ | 53.57▼ | 53.40▼ | 52.90▲ |
| MA20 | 53.10▲ | 53.64▼ | 53.18▲ | 53.83▼ | 57.85▼ |
| MA50 | 53.54▼ | 52.65▲ | 52.56▲ | 53.03▲ | 65.39▼ |
| MA100 | 53.55▼ | 52.72▲ | 53.80▼ | 58.85▼ | 59.20▼ |
| MA200 | 53.17▲ | 53.87▼ | 53.39▼ | 65.09▼ | 41.12▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.051▲ | -0.163▼ | -0.022▼ | -0.208▼ | -0.270▼ |
| RSI | 54.881▲ | 50.084▲ | 53.017▲ | 49.743▼ | 44.264▼ |
| STOCH | 44.023 | 24.097 | 43.260 | 30.192 | 33.138 |
| WILL %R | -5.217▲ | -70.098 | -70.098 | -49.781 | -61.298 |
| CCI | 111.355▲ | -82.943 | -71.368 | -5.887 | -65.338 |
| MA | $LB Price Crossed Above MA(50) | Set Alert |
|
Thursday, October 16, 2025 05:23 AM
Company underscores clinical execution and confirms advanced negotiations underway on acquisition of complementary oncology assets BOCA RATON, ...
|
|
Tuesday, October 14, 2025 05:41 AM
LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced the appointment of James Rawls, Pharm.D., as Senior Vice President of Regulatory Affairs. Throughout his ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/10/25 | 53.78 | 54.81 | 52.835 | 53.38 | 260,731 |
| 15/10/25 | 51.92 | 54.73 | 51.92 | 53.13 | 516,998 |
| 14/10/25 | 50.16 | 52.47 | 50.00 | 51.53 | 223,793 |
| 13/10/25 | 49.40 | 51.81 | 49.3501 | 51.80 | 537,340 |
| 10/10/25 | 53.01 | 53.56 | 48.80 | 48.86 | 580,656 |
| 09/10/25 | 54.15 | 55.70 | 52.36 | 53.11 | 433,100 |
| 08/10/25 | 53.99 | 55.063 | 53.35 | 54.08 | 301,389 |
| 07/10/25 | 57.32 | 57.32 | 53.66 | 54.41 | 430,000 |
| 06/10/25 | 56.60 | 57.92 | 56.00 | 57.08 | 376,200 |
| 03/10/25 | 56.92 | 57.28 | 55.42 | 56.67 | 545,200 |
|
|
||||
|
|
||||
|
|